Recent Finacing
Recent Raise
EpiEndo Pharmaceuticals is a Reykjavik-based clinical-stage biopharma developing first-in-class oral macrolide therapies, led by glasmacinal for COPD.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at EpiEndo Pharmaceuticals.
